Skip to content
Back to ENLT

Enlight Renewable Energy Ltd.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
38
Purchases
0
Sales
38
Purchase value
$0.00
Sale value
$30.80M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Nir YehudaCFO
4
Filed Oct 5, 2026Period of report Oct 1, 20260001976408-26-000886
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 1, 2026
Ordinary shares, NIS 0.1 par value per shareF1F21,276$66.4016$84.73K34,324Direct
Filing footnotes · 2
  1. F1The shares sold represent shares withheld and sold by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted share units
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $66.2338 to $66.6558. These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS). The exchange rate in effect on the transaction date was 3.08 ILS to $1.000 . The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request
Open on SEC EDGAR
Ilan GorenGENERAL MANAGER, ENLIGHT US
4
Filed Oct 5, 2026Period of report Oct 1, 20260001976408-26-000885
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 1, 2026
Ordinary shares, NIS 0.1 par value per shareF12,700$64.81$174.99K40,135Direct
Filing footnotes · 1
  1. F1The shares sold represent shares withheld and sold by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted share units
Open on SEC EDGAR
Amit PazCHIEF INNOVATION OFFICER
4
Filed Sep 15, 2026Period of report Sep 14, 20260001976408-26-000843
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 14, 2026
Ordinary shares, NIS 0.1 par value per shareF12,221$73.9387$164.22K277,462Direct
Filing footnotes · 4
  1. F1The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $73.7947 to $74.2867. These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS). The exchange rate in effect on the transaction date was 3.049 ILS to $1.000 . The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request
  2. F2Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  3. F3Stock options were granted on October 1, 2025, with 11,221 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029.
  4. F4No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Open on SEC EDGAR
Amit PazCHIEF INNOVATION OFFICER
4
Filed Sep 14, 2026Period of report Sep 9, 20260001976408-26-000840
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 9, 2026
Ordinary shares, NIS 0.1 par value per shareF1F24,329$76.5742$331.49K279,683Direct
Filing footnotes · 5
  1. F1The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $76.5661 to $76.5993. These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS). The exchange rate in effect on the transaction date was 3.017 ILS to $1.000. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request
  2. F2The amount reported excludes a fractional share resulting from the issuer's share consolidation (reverse stock split). As a result, the balance reported herein has been rounded down to the nearest whole share and may differ from amounts previously reported.
  3. F3Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  4. F4Stock options were granted on October 1, 2025, with 11,221 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029.
  5. F5No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Open on SEC EDGAR
Israeli Ayelet CohenVP OPERATIONS
4
Filed Jun 2, 2026Period of report Jun 1, 20260001178913-26-003044
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Ordinary shares, NIS 0.1 par value per shareF1F23,250$108.50$352.63K20,974Direct
SaleJun 1, 2026
Ordinary shares, NIS 0.1 par value per shareF5F26,873$108.50$745.72K20,974Direct
Filing footnotes · 9
  1. F1Represents a transaction price of NIS 304.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.811 as of the date immediately preceding the date of the transaction.
  2. F2Includes (i) 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 21, 2027, and 3,257 vesting on April 21, 2028; and (ii) 11,198 restricted share units granted on October 1, 2025, with 2,799 vesting on each of October 1, 2026 and October 1, 2028, and 2,800 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  4. F4These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  5. F5Represents a transaction price of NIS 304.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.811 as of the date immediately preceding the date of the transaction.
  6. F6Stock options were granted on September 30, 2021, with each having vested on September 30, 2025.
  7. F7Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  8. F8Stock options were granted on October 1, 2025, with 12,732 vesting on each of October 1, 2026 and October 1, 2028, and 12,733 vesting on each of October 1, 2027 and October 1, 2029.
  9. F9No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Open on SEC EDGAR
Michal TzukDirector
4
Filed Jun 1, 2026Period of report May 29, 20260001178913-26-003015
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 29, 2026
Ordinary shares, NIS 0.1 par value per shareF1F22,400$105.86$254.06K2,712Direct
Filing footnotes · 2
  1. F1Represents a transaction price of NIS 300.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.834 as of the date immediately preceding the date of the transaction.
  2. F2Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
Open on SEC EDGAR
Yair SeroussiDirector · VICE CHAIRMAN OF THE BOARD
4
Filed Jun 1, 2026Period of report May 28, 20260001178913-26-003013
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 28, 2026
Ordinary shares, NIS 0.1 par value per shareF4F212,036$102.24$1.23M14,233Direct
Filing footnotes · 9
  1. F1Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F2Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  4. F4Represents a transaction price of NIS 290.35, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
  5. F5Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025.
  6. F6Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  7. F7Stock options were granted on October 1, 2025, with 12,893 vesting on each of October 1, 2026, and October 1, 2028, and 12,894 vesting on each of October 1, 2027, and October 1, 2029.
  8. F8No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
  9. F9Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 2,834 on October 1, 2026, and 2,835 on each of October 1, 2027, 2028, and 2029, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.
Open on SEC EDGAR
Alla FelderDirector
4
Filed Jun 1, 2026Period of report May 28, 20260001178913-26-003011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 28, 2026
Ordinary shares, NIS 0.1 par value per shareF1F22,500$102.48$256.20K2,612Direct
Filing footnotes · 2
  1. F1Represents a transaction price of NIS 291.05, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
  2. F2Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
Open on SEC EDGAR
Lisa HaimovitzVP, GENERAL COUNSEL
4
Filed Jun 1, 2026Period of report May 28, 20260001178913-26-003009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 28, 2026
Ordinary shares, NIS 0.1 par value per shareF4F2746$103.88$77.49K13,026Direct
Filing footnotes · 5
  1. F1Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F2Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  4. F4Represents a transaction price of NIS 295.01, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
  5. F5Stock options were granted on April 24, 2023, with 52,500 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027.
Open on SEC EDGAR
Meron CarrSVP, STRATEGIC PROJECTS
4
Filed May 28, 2026Period of report May 27, 20260001178913-26-002985
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 28, 2026
Ordinary shares, NIS 0.1 par value per shareF5F23,329$103.44$344.35K42,465Direct
SaleMay 27, 2026
Ordinary shares, NIS 0.1 par value per shareF4F23,074$103.88$319.33K42,465Direct
Filing footnotes · 9
  1. F1Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F2Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  4. F4Represents a transaction price of NIS 296.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
  5. F5Represents a transaction price of NIS 293.78, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
  6. F6Stock options were granted on September 30, 2021, with each having vested on September 30, 2025.
  7. F7Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  8. F8Stock options were granted on October 1, 2025, with 22,441 vesting on October 1, 2026, and 22,442 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.
  9. F9No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Open on SEC EDGAR
Yitzhak BetzalelDirector
4
Filed May 28, 2026Period of report May 27, 20260001178913-26-002977
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 28, 2026
Ordinary shares, NIS 0.1 par value per shareF3F2600$102.96$61.78K3,166Direct
SaleMay 28, 2026
Ordinary shares, NIS 0.1 par value per shareF4F2400$103.52$41.41K2,766Direct
SaleMay 28, 2026
Ordinary shares, NIS 0.1 par value per shareF5F2500$103.54$51.77K2.266Direct
SaleMay 28, 2026
Ordinary shares, NIS 0.1 par value per shareF6F2500$104.58$52.29K1,766Direct
SaleMay 28, 2026
Ordinary shares, NIS 0.1 par value per shareF7F262$104.23$6.46K1,704Direct
SaleMay 27, 2026
Ordinary shares, NIS 0.1 par value per shareF1F21,346$101.73$136.93K3,766Direct
Filing footnotes · 7
  1. F1Represents a transaction price of NIS 290.86, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
  2. F2Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3Represents a transaction price of NIS 292.40, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
  4. F4Represents a transaction price of NIS 294.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
  5. F5Represents a transaction price of NIS 294.05, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
  6. F6Represents a transaction price of NIS 297.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
  7. F7Represents a transaction price of NIS 296.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
Open on SEC EDGAR
Liat BenyaminiDirector
4
Filed May 28, 2026Period of report May 27, 20260001178913-26-002975
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 28, 2026
Ordinary shares, NIS 0.1 par value per shareF3F22,132$102.61$218.76K2,704Direct
SaleMay 27, 2026
Ordinary shares, NIS 0.1 par value per shareF1F2276$101.43$27.99K4,836Direct
Filing footnotes · 3
  1. F1Represents a transaction price of NIS 290.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
  2. F2Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3Represents a transaction price of NIS 291.41, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
Open on SEC EDGAR
Lisa HaimovitzVP, GENERAL COUNSEL
4
Filed May 28, 2026Period of report May 27, 20260001178913-26-002970
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 27, 2026
Ordinary shares, NIS 0.1 par value per shareF4F22,807$103.75$291.23K13,026Direct
Filing footnotes · 5
  1. F1Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F2Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  4. F4Represents a transaction price of NIS 296.61, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
  5. F5Stock options were granted on April 24, 2023, with 52,500 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027.
Open on SEC EDGAR
Ilan GorenGENERAL MANAGER, ENLIGHT US
4
Filed May 28, 2026Period of report May 27, 20260001178913-26-002968
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 27, 2026
Ordinary shares, NIS 0.1 par value per shareF4F226,622$103.76$2.76M42,835Direct
Filing footnotes · 10
  1. F1Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F10Stock options were granted on July 29, 2025, with 24,685 vesting on October 1, 2026; and 24,686 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.
  3. F2Includes (i) 14,083 restricted share units granted on April 21, 2024, with 7,041 vesting on April 21, 2027 and 7,042 vesting on April 21, 2028; and (ii) 21,710 restricted share units granted on July 29, 2025, with 5,427 vesting on each of October 1, 2026 and October 1, 2028, and 5,428 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  4. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  5. F4Represents a transaction price of NIS 296.66, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
  6. F5Stock options were granted on September 30, 2021, with 35,000 having vested on September 30, 2024; and 30,000 having vested on September 30, 2025.
  7. F6Represents an exercise price of NIS 68.64, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  8. F7Stock options were granted on June 28, 2022, with 25,000 having vested on each of June 28, 2023 and June 28, 2024; 35,000 having vested on June 28, 2025; and 15,000 vesting on June 28, 2026.
  9. F8No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
  10. F9Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
Open on SEC EDGAR
Lisa HaimovitzVP, GENERAL COUNSEL
4
Filed May 27, 2026Period of report May 25, 20260001178913-26-002919
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 26, 2026
Ordinary shares, NIS 0.1 par value per shareF5F25,436$99.30$539.79K13,026Direct
SaleMay 25, 2026
Ordinary shares, NIS 0.1 par value per shareF4F25,315$93.84$498.76K13,026Direct
Filing footnotes · 6
  1. F1Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F2Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  4. F4Represents a transaction price of NIS 272.80, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.
  5. F5Represents a transaction price of NIS 283.90, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
  6. F6Stock options were granted on April 24, 2023, with 52,500 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027.
Open on SEC EDGAR
Amit PazCHIEF INNOVATION OFFICER
4
Filed May 26, 2026Period of report May 26, 20260001178913-26-002912
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 26, 2026
Ordinary shares, NIS 0.1 par value per shareF1F23,533$97.35$343.94K284,012.1Direct
Filing footnotes · 5
  1. F1Represents a transaction price of NIS 283.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.
  2. F2Includes (i) 12,627 restricted share units granted on April 24, 2024, with 6,313 vesting on April 24, 2027 and 6,314 vesting on April 21, 2028; and (ii) 9,868 restricted share units granted on October 1, 2025, with 2,467 vesting on each of October 1, 2026, October 1, 2027, October 1,2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  4. F4Stock options were granted on October 1, 2025, with 11,221 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029.
  5. F5No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Open on SEC EDGAR
Yair SeroussiDirector · VICE CHAIRMAN OF THE BOARD
4
Filed May 26, 2026Period of report May 25, 20260001178913-26-002890
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 25, 2026
Ordinary shares, NIS 0.1 par value per shareF4F23,593$94.24$338.60K14,233Direct
SaleMay 25, 2026
Ordinary shares, NIS 0.1 par value per shareF5F210,779$93.04$1.00M14,233Direct
Filing footnotes · 10
  1. F1Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F10Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 2,834 on October 1, 2026, and 2,835 on each of October 1, 2027, 2028, and 2029, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.
  3. F2Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  4. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  5. F4Represents a transaction price of NIS 273.97, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.
  6. F5Represents a transaction price of NIS 270.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.
  7. F6Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025.
  8. F7Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  9. F8Stock options were granted on October 1, 2025, with 12,893 vesting on each of October 1, 2026, and October 1, 2028, and 12,894 vesting on each of October 1, 2027, and October 1, 2029.
  10. F9No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Open on SEC EDGAR
Shai Yeshayahu WeilDirector
4
Filed May 26, 2026Period of report May 25, 20260001178913-26-002888
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 25, 2026
Ordinary shares, NIS 0.1 par value per shareF1F273,436$93.68$6.88M396,655IndirectBy Givon Investments Partnership (GAAS)
Filing footnotes · 4
  1. F1Represents a price of NIS 272.34, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.
  2. F2The reporting person is a general partner of Givon Investments Partnership (GAAS), the partnership that owns the reported securities. The partnership is controlled by the Weil family of which the reporting person is a part. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  3. F3Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  4. F4No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Open on SEC EDGAR
Gilad YavetzDirector · EXEC. CHAIRMAN OF THE BOARD
4
Filed May 14, 2026Period of report May 13, 20260001178913-26-002668
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 13, 2026
Ordinary shares, NIS 0.1 par value per shareF4F256,489$91.78$5.18M889,947.1Direct
SaleMay 13, 2026
Ordinary shares, NIS 0.1 par value per shareF4F243,511$91.78$3.99M846,436.1Direct
Filing footnotes · 9
  1. F1Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F2Includes (i) 43,512 restricted share units granted on April 17, 2024, with 21,756 vesting on each of April 17, 2027 and April 17, 2028; and (ii) 6,726 restricted share units granted on October 1, 2025, with 1,681 vesting on October 1, 2026, 1,682 vesting on October 1, 2027, 1,681 vesting on October 1, 2028, and 1,682 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  4. F4Represents a transaction price of NIS 267.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction.
  5. F5Stock options were granted on September 30, 2021, with 24,997 having vested on September 30, 2023, 50,000 having vested on December 30, 2023, 50,000 having vested on March 30, 2023, 50,000 having vested on June 30, 2023, 50,000 having vested on September 30, 2024, 12,500 having vested on December 30, 2024, 12,500 having vested on March 30, 2025, 12,500 having vested on June 30, 2025, and 12,500 having vested on September 30, 2025.
  6. F6Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  7. F7Stock options were granted on October 1, 2025, with 86,481 vesting on October 1, 2026, and 86,482 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.
  8. F8No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
  9. F9Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 19,013 on October 1, 2026, and 19,014 on each of October 1, 2027, 2028, and 2029, beginning 12 months after the grant date, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.
Open on SEC EDGAR
Nir YehudaCHIEF FINANCIAL OFFICER
4
Filed May 14, 2026Period of report May 12, 20260001178913-26-002665
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 13, 2026
Ordinary shares, NIS 0.1 par value per shareF3F41,149$93.23$107.12K35,600Direct
SaleMay 12, 2026
Ordinary shares, NIS 0.1 par value per shareF1F25,796$92.83$538.04K36,749Direct
Filing footnotes · 7
  1. F1Represents a transaction price of NIS 270.03, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction.
  2. F2Consists of (i) 15,039 restricted share units granted on April 21, 2024, with 1,149 having vesting on April 21, 2026, and 6,945 vesting on each of April 21, 2027 and April 21, 2028; and (ii) 21,710 restricted share units granted on October 1, 2025, with 5,427 vesting on October 1, 2026, 5,428 vesting on October 1, 2027, 5,427 vesting on October 1, 2028 and 5,428 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3Represents a transaction price of NIS 271.21, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction.
  4. F4Consists of (i) 13,890 restricted share units granted on April 21, 2024, with 6,945 vesting on each of April 21, 2027 and April 21, 2028; and (ii) 21,710 restricted share units granted on October 1, 2025, with 5,427 vesting on October 1, 2026, 5,428 vesting on October 1, 2027, 5,427 vesting on October 1, 2028 and 5,428 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  5. F5Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  6. F6Stock options were granted on October 1, 2025, with 24,685 vesting on October 1, 2026 and 24,686 vesting on each of October 1, 2027, October 1, 2028 and October 1, 2029.
  7. F7No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Open on SEC EDGAR
Lisa HaimovitzVP, GENERAL COUNSEL
4
Filed May 14, 2026Period of report May 12, 20260001178913-26-002663
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 13, 2026
Ordinary shares, NIS 0.1 par value per shareF5F2620$93.84$58.18K13,026Direct
SaleMay 12, 2026
Ordinary shares, NIS 0.1 par value per shareF4F23,883$92.67$359.84K13,026Direct
Filing footnotes · 7
  1. F1Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F2Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  4. F4Represents a transaction price of NIS 269.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction.
  5. F5Represents a transaction price of NIS 272.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction.
  6. F6Stock options were granted on April 24, 2023, with 46,543 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027.
  7. F7Stock options were granted on April 24, 2023, with 43,840 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027.
Open on SEC EDGAR
Marko LiposcakGENERAL MANAGER, ENLIGHT EU
4
Filed May 13, 2026Period of report May 12, 20260001178913-26-002621
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 12, 2026
Ordinary shares, NIS 0.1 par value per shareF1F26,402$92.53$592.38K32,539Direct
Filing footnotes · 5
  1. F1Represents a transaction price of NIS 269.16, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction.
  2. F2Consists of (i) 12,803 restricted share units granted on April 21, 2024, with 6,401 vesting on April 21, 2027 and 6,402 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  4. F4Stock options were granted on October 1, 2025, with 22,441 vesting on October 1, 2026, and 22,442 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.
  5. F5No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Open on SEC EDGAR
Yair SeroussiDirector · VICE CHAIRMAN OF THE BOARD
4
Filed May 11, 2026Period of report May 7, 20260001178913-26-002492
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 8, 2026
Ordinary shares, NIS 0.1 par value per shareF5F23,033$89.04$270.06K14,233Direct
SaleMay 7, 2026
Ordinary shares, NIS 0.1 par value per shareF4F222,505$90.63$2.04M14,233Direct
Filing footnotes · 10
  1. F1Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F10Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 2,834 on October 1, 2026, and 2,835 on each of October 1, 2027, 2028, and 2029, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.
  3. F2Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  4. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  5. F4Represents a transaction price of NIS 263.11, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.903 as of the date immediately preceding the date of the transaction.
  6. F5Represents a transaction price of NIS 258.85, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.
  7. F6Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025.
  8. F7Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  9. F8Stock options were granted on October 1, 2025, with 12,893 vesting on each of October 1, 2026, and October 1, 2028, and 12,894 vesting on each of October 1, 2027, and October 1, 2029.
  10. F9No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Open on SEC EDGAR
Lisa HaimovitzVP, GENERAL COUNSEL
4
Filed May 11, 2026Period of report May 7, 20260001178913-26-002495
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 7, 2026
Ordinary shares, NIS 0.1 par value per shareF4F2737$92.75$68.36K13,026Direct
Filing footnotes · 5
  1. F1Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  2. F2Includes 6,513 restricted share units granted on April 21, 2024, with 3,257 vesting on April 24, 2028 and 3,256 vesting on April 24, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  3. F3These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  4. F4Represents a transaction price of NIS 269.26, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.903 as of the date immediately preceding the date of the transaction.
  5. F5Stock options were granted on April 24, 2023, with 52,500 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.